Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testin LIM domain protein is a cytoskeletal scaffold and signaling integrator found at focal adhesions and along actin stress fibers, encoded by the TES gene. It is characterized by three C-terminal LIM domains and a PET domain, allowing for versatile protein-protein associations. Testin promotes cell adhesion, cytoskeleton maintenance, and suppresses tumorigenesis. It is mainly studied in cancer biology, as its loss leads to disrupted cell structure and increased metastatic capacity. Testin interacts with zyxin, actin, MENA (ENAH), VASP, alpha-actinin, paxillin, talin, ALKBH4, GRIP1 and other focal adhesion partners, mediating its function as a tumor suppressor[1][5][6][7].\n\nTestin LIM domain protein is not a classic receptor, enzyme, transporter, or transcription factor, but belongs to the LIM domain scaffold/cytoskeletal regulators, and is characterized primarily as a tumor suppressor with important roles in cellular structure, adhesion, and cancer pathophysiology[1][2][5][6].
No drugs directly targeting TES; hypothetical/experimental mechanisms would involve mimicking TES's interaction with MENA to inhibit cancer cell motility[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testin LIM domain protein (TES).